“Shared Work – Shared Vision” – Our Collaborative Approach to Supporting Ophthalmology Clinical Trials

Somewhere in the world, someone goes blind every five seconds. A child goes blind every minute. Of the 119 million people in the United States who are age 40 or over, 3.4 million are visually impaired or blind. A leading cause of blindness in the U.S. is glaucoma but half of the nearly 3 million people afflicted with the disease do not realize it because there are often no warning symptoms. The facts about blindness and eye health make it clear the need for new ophthalmic treatments is acute.

At SynteractHCR, we have been at the forefront of ophthalmology clinical development. We have developed a specialized clinical operations and therapeutic focus on ophthalmology studies with experienced project teams dedicated to all ophthalmic programs. Our experienced staff has conducted 140 studies on more than 23,700 patients in a wide variety of indications.

SynteractHCR Ophthalmology Expertise

  • Cataracts 
  • Corneal Opacity
  • Corneaplasty
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Glaucoma
  • Intraocular Lens
  • Macular Degeneration
  • Macular Edema
  • Polypoidal Choroidal Vasculopathy
  • Post Vitrectomy Inflammation
  • Posterior Segment Diseases
  • Posterior Vitreous Detachment
  • Retinal Vein Occlusion
  • Vitreous Hemorrhage

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:

Required Fields(*)